Below are this phase 2s table of key outcomes, alongside retatrutides effects versus other drugs for fatty liver disease
Symptoms include itching, rash, or breathing issues
Benefits Darker tan with less exposure to UV radiation Tanning without sunburn, even for fair-skinned individuals Possible reduction in the risk of Melanoma (skin cancer) Possible reduction in the incidence of sun-damaged skin Possible reduction in body fat No sunburn or tan lines No sunless tanning streaks or fake tan removal Possible increase in libido During clinical trials for its use as a tanning agent, melanotan II was found to be a potent stimulator of male erections
In the higher-dose groups, HbA1c fell by roughly two percentage points, alongside meaningful body-weight change
To be eligible, patients must: Be 18 years or older and not pregnant Have a Body Mass Index (BMI) of 30 kg/m to qualify for any of the medications, or Have a BMI of 27 kg/m with at least one weight-related risk factor (e.g., high blood pressure, type 2 diabetes, high cholesterol) to start Phentermine, Phentermine +Topiramate, Metformin, or compounded Tirzepatide, or Have a BMI of 25 kg/m with at least one weight-related risk factor (e.g
1 Flow chart of the review process